DXB 1.64% 30.0¢ dimerix limited

has anyone else considered the impact of the recent impressive...

  1. 206 Posts.
    lightbulb Created with Sketch. 163
    has anyone else considered the impact of the recent impressive results in kidney disease progression.

    the CREDENCE trial Released results at the major Australian Nephrology conference last week and announced some pretty amazing reductions in negative disease outcomes.

    I'm not a pharmacist so would be interested to know if anyone with relevant knowledge could speak to whether this treatment works on similar pathways, or if DXB-200 could work in unison.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.005(1.64%)
Mkt cap ! $164.5M
Open High Low Value Volume
31.0¢ 31.0¢ 30.0¢ $818.6K 2.683M

Buyers (Bids)

No. Vol. Price($)
12 572150 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 10850 1
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
30.0¢
  Change
-0.005 ( 1.64 %)
Open High Low Volume
31.0¢ 31.0¢ 30.0¢ 640607
Last updated 15.54pm 29/03/2024 ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.